Literature DB >> 29935783

Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.

John C Hardaway1, Ethan Prince2, Aravind Arepally3, Steven C Katz4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29935783     DOI： 10.1016/j.jvir.2018.03.001

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  8 in total

1.  Potential of Chimeric Antigen Receptor T-Cells in Cancer Therapy.

Authors:  Drashti Desai; R S Gaud; Pravin Shende
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The evolution of interventional oncology in the 21st century.

Authors:  Thomas Helmberger
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.039

Review 3.  Engineering strategies to overcome the current roadblocks in CAR T cell therapy.

Authors:  Sarwish Rafiq; Christopher S Hackett; Renier J Brentjens
Journal:  Nat Rev Clin Oncol       Date:  2019-12-17       Impact factor: 65.011

4.  Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer.

Authors:  Jiang Lv; Ruocong Zhao; Di Wu; Diwei Zheng; Zhiping Wu; Jingxuan Shi; Xinru Wei; Qiting Wu; Youguo Long; Simiao Lin; Suna Wang; Zhi Wang; Yang Li; Yantao Chen; Qing He; Suimin Chen; Huihui Yao; Zixia Liu; Zhaoyang Tang; Yao Yao; Duanqing Pei; Pentao Liu; Xuchao Zhang; Zhenfeng Zhang; Shuzhong Cui; Ren Chen; Peng Li
Journal:  J Hematol Oncol       Date:  2019-02-18       Impact factor: 17.388

Review 5.  The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies.

Authors:  Andriy Zhylko; Magdalena Winiarska; Agnieszka Graczyk-Jarzynka
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 6.  Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors.

Authors:  Yasushi Kimura; Mario Ghosn; Waseem Cheema; Prasad S Adusumilli; Stephen B Solomon; Govindarajan Srimathveeralli
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

Review 7.  Challenges in assessing solid tumor responses to immunotherapy.

Authors:  Louis F Chai; Ethan Prince; Venu G Pillarisetty; Steven C Katz
Journal:  Cancer Gene Ther       Date:  2019-12-11       Impact factor: 5.987

8.  HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery.

Authors:  Steven C Katz; Ashley E Moody; Prajna Guha; John C Hardaway; Ethan Prince; Jason LaPorte; Mirela Stancu; Jill E Slansky; Kimberly R Jordan; Richard D Schulick; Robert Knight; Abdul Saied; Vincent Armenio; Richard P Junghans
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.